RBFC
AMGN icon

Roman Butler Fullerton & Co’s Amgen AMGN Stock Holding History

Roman Butler Fullerton & Co’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$675K Buy
1,929
+43
+2% +$15.3K 0.19% 133
2025
Q4 		$655K Sell
1,886
-41
-2% -$13K 0.17% 143
2025
Q3 		$562K Sell
1,927
-35
-2% -$10.2K 0.15% 145
2025
Q2 		$601K Buy
1,962
+31
+2% +$8.78K 0.18% 133
2025
Q1 		$570K Buy
1,931
+2
+0.1% +$591 0.22% 113
2024
Q4 		$546K Sell
1,929
-182
-9% -$54K 0.17% 127
2024
Q3 		$686K Sell
2,111
-119
-5% -$38.9K 0.21% 112
2024
Q2 		$717K Sell
2,230
-516
-19% -$152K 0.23% 98
2024
Q1 		$747K Buy
2,746
+523
+24% +$153K 0.28% 88
2023
Q4 		$693K Buy
2,223
+18
+0.8% +$4.9K 0.27% 91
2023
Q3 		$627K Buy
2,205
+106
+5% +$26.5K 0.3% 89
2023
Q2 		$487K Buy
2,099
+16
+0.8% +$3.71K 0.22% 106
2023
Q1 		$510K Buy
2,083
+15
+0.7% +$3.68K 0.25% 106
2022
Q4 		$557K Sell
2,068
-7
-0.3% -$1.88K 0.29% 101
2022
Q3 		$509K Buy
2,075
+13
+0.6% +$3.15K 0.32% 94
2022
Q2 		$513K Buy
2,062
+13
+0.6% +$3.19K 0.28% 102
2022
Q1 		$496K Buy
2,049
+13
+0.6% +$2.99K 0.23% 114
2021
Q4 		$458K Buy
2,036
+14
+0.7% +$2.96K 0.2% 114
2021
Q3 		$411K Buy
2,022
+12
+0.6% +$2.76K 0.19% 124
2021
Q2 		$490K Sell
2,010
-20
-1% -$4.92K 0.24% 109
2021
Q1 		$510K Hold
2,030
– – 0.26% 110
2020
Q4 		$467K Buy
2,030
+55
+3% +$12.7K 0.28% 99
2020
Q3 		$502K Buy
1,975
+9
+0.5% +$2.23K 0.33% 92
2020
Q2 		$464K Sell
1,966
-2,379
-55% -$543K 0.33% 93
2020
Q1 		$881K Sell
4,345
-1,196
-22% -$261K 0.78% 44
2019
Q4 		$1.34M Buy
5,541
+14
+0.3% +$3.09K 0.88% 29
2019
Q3 		$1.07M Sell
5,527
-465
-8% -$89.3K 0.74% 41
2019
Q2 		$1.1M Buy
5,992
+1,550
+35% +$278K 0.74% 37
2019
Q1 		$844K Buy
4,442
+815
+22% +$156K 0.59% 54
2018
Q4 		$735K Buy
+3,627
New +$708K 0.62% 57

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Roman Butler Fullerton & Co's AMGN Position: Q1 2026 in Review

Roman Butler Fullerton & Co increased its Amgen (AMGN) stake by 2.3% in Q1 2026, buying an estimated $15.3K and bringing the position to 1,929 shares worth $675K. The position accounts for 0.19% of the portfolio, ranked #133.

Roman Butler Fullerton & Co first reported a position in AMGN in Q4 2018 and has held it in 30 quarters since. The position peaked at $1.34M in Q4 2019. 3,130 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Roman Butler Fullerton & Co held 1,929 shares of Amgen worth $675K as of Q1 2026.
  • Roman Butler Fullerton & Co bought 43 Amgen shares in Q1 2026, an estimated $15.3K.
  • Amgen made up 0.19% of Roman Butler Fullerton & Co's portfolio in Q1 2026, its #133 holding.
  • Roman Butler Fullerton & Co first reported a position in Amgen in Q4 2018 and has held it in 30 quarters since.
  • Roman Butler Fullerton & Co's Amgen position peaked at $1.34M in Q4 2019.
  • 3,130 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Roman Butler Fullerton & Co's 13F filing for Q1 2026, filed 30 Apr 2026.